Related Experiment Video
Updated: Jul 23, 2026

10:28
An Injectable and Drug-loaded Supramolecular Hydrogel for Local Catheter Injection into the Pig Heart
Published on: June 7, 2015
17.3K
Nanofiber Hydrogel Drug Delivery System for Prevention of Postsurgical Intestinal Adhesion
Bei Zhao1, Panyong Zhu1, Hongyu Zhang1
1Zhoukou Central Hospital, Zhoukou 466001, China.
ACS Biomaterials Science & Engineering
|April 26, 2024
Summary
A novel dual-drug patch effectively prevents postsurgical intestinal adhesion (PIA) by combining anti-inflammatory and pro-repair drugs. This innovation offers a promising solution for reducing complications after abdominal surgery.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Surgical Innovation
Background:
- Postsurgical intestinal adhesion (PIA) is a frequent complication of abdominal surgery, leading to significant health issues like obstruction and infertility.
- Current prevention methods using hydrogels or nanofibrous films have limitations.
- Developing advanced barrier materials is crucial for mitigating PIA.
Purpose of the Study:
- To develop a novel dual-structure drug delivery patch for preventing postsurgical intestinal adhesion.
- To investigate the efficacy of a combined anti-inflammatory and pro-repair drug delivery system.
Main Methods:
- A dual-structure patch (NHP) was created using poly lactic-co-glycolic acid (PLGA) nanofibers and a chitosan hydrogel.
- PLGA nanofibers were loaded with deferoxamine mesylate (DFO) for sustained release.
- The chitosan hydrogel was loaded with dexamethasone (DXMS) for rapid release.
Main Results:
- The hydrogel component rapidly released DXMS, providing acute anti-inflammatory effects.
- The PLGA nanofibers sustained DFO release, promoting peritoneal repair via angiogenesis.
- In vivo studies demonstrated that NHP effectively prevented PIA by reducing inflammation and vascularization.
Conclusions:
- The NHP patch successfully inhibits postsurgical intestinal adhesion.
- This dual-drug delivery system shows significant potential for clinical application in preventing PIA.
- NHP offers a promising strategy for improving surgical outcomes and patient recovery.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...

